Aardvark Therapeutics Inc. Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| DECHENG CAPITAL LLC | 05/13/2026 | 3.92 M | $14.77 M | 0.00% | 19.96% |
| CITADEL ADVISORS LLC | 05/15/2026 | 1.24 M | $4.69 M | -3.61% | 6.33% |
| LAURION CAPITAL MANAGEMENT LP | 05/14/2026 | 1.03 M | $3.90 M | 1.93% | 5.27% |
| BLACKROCK, INC. | 05/13/2026 | 792.57 K | $2.99 M | 1.04% | 4.04% |
| 05/15/2026 | 554.10 K | $2.09 M | 100.00% | 2.82% | |
| TFG ASSET MANAGEMENT GP LTD | 05/15/2026 | 316.62 K | $1.19 M | 100.00% | 1.61% |
| GEODE CAPITAL MANAGEMENT, LLC | 05/15/2026 | 309.45 K | $1.17 M | 3.89% | 1.58% |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 05/15/2026 | 300.00 K | $1.13 M | 100.00% | 1.53% |
| STATE STREET CORP | 05/15/2026 | 199.32 K | $751.44 K | 25.96% | 1.02% |
| TWO SIGMA INVESTMENTS, LP | 05/15/2026 | 163.36 K | $615.85 K | 26.84% | 0.83% |
| UBS GROUP AG | 05/05/2026 | 157.89 K | $595.24 K | 488.30% | 0.80% |
| AQR CAPITAL MANAGEMENT LLC | 05/15/2026 | 134.50 K | $507.05 K | 100.00% | 0.69% |
| MILLENNIUM MANAGEMENT LLC | 05/15/2026 | 98.33 K | $370.72 K | -79.66% | 0.50% |
| NORTHERN TRUST CORP | 05/14/2026 | 88.60 K | $334.02 K | -0.78% | 0.45% |
| VANGUARD FIDUCIARY TRUST CO | 05/08/2026 | 83.21 K | $313.70 K | 100.00% | 0.42% |
| 05/08/2026 | 75.15 K | $283.31 K | 100.00% | 0.38% | |
| WOODLINE PARTNERS LP | 05/15/2026 | 72.43 K | $273.06 K | 100.00% | 0.37% |
| RENAISSANCE TECHNOLOGIES LLC | 05/14/2026 | 70.79 K | $266.89 K | 100.00% | 0.36% |
| CANTOR FITZGERALD, L. P. | 05/15/2026 | 66.68 K | $251.39 K | -27.27% | 0.34% |
| CITADEL ADVISORS LLC | 05/15/2026 | 52.90 K | $199.43 K | 100.00% | 0.27% |
| CITIGROUP INC | 05/11/2026 | 46.27 K | $174.42 K | 5,063.50% | 0.24% |
| CRESSET ASSET MANAGEMENT, LLC | 05/15/2026 | 43.26 K | $163.09 K | 100.00% | 0.22% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 05/14/2026 | 33.68 K | $126.99 K | -88.92% | 0.17% |
| PRELUDE CAPITAL MANAGEMENT, LLC | 05/15/2026 | 30.64 K | $115.50 K | 100.00% | 0.16% |
| BANK OF NEW YORK MELLON CORP | 05/05/2026 | 29.32 K | $110.54 K | 30.81% | 0.15% |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 05/15/2026 | 28.00 K | $105.56 K | -11.20% | 0.14% |
| GSA CAPITAL PARTNERS LLP | 05/08/2026 | 27.09 K | $102.00 K | -24.60% | 0.14% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 05/15/2026 | 27.00 K | $101.79 K | 0.00% | 0.14% |
| CENTIVA CAPITAL, LP | 05/14/2026 | 24.78 K | $93.43 K | -74.59% | 0.13% |
| JANE STREET GROUP, LLC | 05/12/2026 | 20.00 K | $75.40 K | 100.00% | 0.10% |
| XTX TOPCO LTD | 05/15/2026 | 19.92 K | $75.08 K | -22.05% | 0.10% |
| GOLDMAN SACHS GROUP INC | 05/15/2026 | 19.40 K | $73.15 K | -63.63% | 0.10% |
| DEUTSCHE BANK AG\ | 05/06/2026 | 17.90 K | $67.49 K | 180.32% | 0.09% |
| ALPS ADVISORS INC | 05/08/2026 | 17.73 K | $66.83 K | -0.84% | 0.09% |
| MORGAN STANLEY | 05/15/2026 | 17.56 K | $66.21 K | -77.47% | 0.09% |
| IEQ CAPITAL, LLC | 05/15/2026 | 16.49 K | $62.15 K | 100.00% | 0.08% |
| NUVEEN, LLC | 04/30/2026 | 15.31 K | $57.73 K | -62.67% | 0.08% |
| BANK OF AMERICA CORP /DE/ | 05/18/2026 | 11.49 K | $43.30 K | -62.54% | 0.06% |
| RAYMOND JAMES FINANCIAL INC | 05/14/2026 | 10.89 K | $41.06 K | 100.00% | 0.06% |
| FMR LLC | 05/15/2026 | 8.96 K | $33.77 K | 613.22% | 0.05% |
| RHUMBLINE ADVISERS | 05/12/2026 | 6.68 K | $25.17 K | -11.58% | 0.03% |
| JPMORGAN CHASE & CO | 05/13/2026 | 6.62 K | $24.09 K | -3.86% | 0.03% |
| MIRAE ASSET GLOBAL ETFS HOLDINGS LTD. | 05/15/2026 | 6.07 K | $22.87 K | 2.29% | 0.03% |
| CWM, LLC | 05/14/2026 | 6.04 K | $22.75 K | 100.00% | 0.03% |
| VANGUARD GLOBAL ADVISERS, LLC | 05/08/2026 | 5.89 K | $22.22 K | 100.00% | 0.03% |
| TOWER RESEARCH CAPITAL LLC (TRC) | 05/15/2026 | 5.47 K | $20.61 K | 574.11% | 0.03% |
| WELLS FARGO & COMPANY/MN | 05/11/2026 | 4.71 K | $17.75 K | -66.57% | 0.02% |
| SIMPLEX TRADING, LLC | 05/14/2026 | 4.24 K | $16.00 K | 100.00% | 0.02% |
| STEWARD PARTNERS INVESTMENT ADVISORY, LLC | 05/08/2026 | 4.15 K | $15.65 K | 100.00% | 0.02% |
| CHINA UNIVERSAL ASSET MANAGEMENT CO., LTD. | 04/28/2026 | 3.86 K | $14.57 K | 8.91% | 0.02% |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
Aardvark Therapeutics Inc. institutional Ownership - FAQ's
During the previous two years, 93 institutional investors and hedge funds held shares of Aardvark Therapeutics Inc.. The most heavily invested institutionals were:
Decheng Capital LLC: 3.92 M
CITADEL ADVISORS LLC: 1.24 M
Laurion Capital Management LP: 1.03 M
BlackRock, Inc.: 792,571
TFG Asset Management GP Ltd: 316,621
GEODE CAPITAL MANAGEMENT, LLC: 309,449
46.75% of Aardvark Therapeutics Inc. stock is owned by institutional investors.
Institutional investors have bought a total of 10.31 M shares in the last 24 months. This purchase volume represents approximately $62.80 M in transactions.